https://orcid.org/0000-0002-7947-8642
References
- Freitag FM, Cestari TF. What causes dark circles under the eyes? J Cosmet Dermatol. 2007;6(3):211–215.
- Roh MR, Chung KY. Infraorbital dark circles: definition, causes, and treatment options. Dermatol Surg. 2009;35(8):1163–1171.
- Malakar S, Lahiri K, Banerjee U, et al. Periorbital melanosis is an extension of pigmentary demarcation line-F on face. Indian J Dermatol Venereol Leprol. 2007;73(5):323–325.
- Rahman Z, Alam M, Dover JS. Fractional laser treatment for pigmentation and texture improvement. Skin Ther Lett. 2006;11(9):7–11.
- Hantash BM, Bedi VP, Kapadia B, et al. In vivo histological evaluation of a novel ablative fractional resurfacing device. Lasers Surg Med. 2007;39(2):96–107.
- Ortiz AE, Tremaine AM, Zachary CB. Long-term efficacy of a fractional resurfacing device. Lasers Surg Med. 2010;42(2):168–170.
- Robati RM, Asadi E. Efficacy and safety of fractional CO2 laser versus fractional Er:YAG laser in the treatment of facial skin wrinkles. Lasers Med Sci. 2017;32(2):283–289.
- Lee JC, Daniels MA, Roth MZ. Mesotherapy, microneedling, and chemical peels. Clin Plast Surg. 2016;43(3):583–595.
- Singh A, Yadav S. Microneedling: advances and widening horizons. Indian Dermatol Online J. 2016;7(4):244–254.
- Maeda K, Naganuma M. Topical trans-4-aminomethylcyclohexanecarboxylic acid prevents ultraviolet radiation-induced pigmentation. J Photochem Photobiol B Biol. 1998;47(2–3):136–141.
- Saad A. News in the treatment of periorbital hyperpigmentation. J Dermatol & Ther. 2017;1:19–23.
- Gendler EC. Treatment of periorbital hyperpigmentation. Aesthet Surg J. 2005;25(6):618–624.
- Fisher GH, Geronemus RG. Short-term side effects of fractional photothermolysis. Dermatol Surg. 2005;31(9 Pt 2):1245–1249.
- Waibel JS, Rudnick A, Shagalov DR, et al. Update of ablative fractionated lasers to enhance cutaneous topical drug delivery. Adv Ther. 2017;34(8):1840–1849.
- Sharad J. Combination of microneedling and glycolic acid peels for the treatment of acne scars in dark skin. J Cosmet Dermatol. 2011;10(4):317–323.
- Doddaballapur S. Microneedling with dermaroller. J Cutan Aesthet Surg. 2009;2(2):110–111.
- Kaushik S, Hord AH, Denson DD, et al. Lack of pain associated with microfabricated microneedles. Anesth Analg. 2001;92(2):502–504.
- Lima EVA, Lima M, Paixao MP, et al. Assessment of the effects of skin microneedling as adjuvant therapy for facial melasma: a pilot study. BMC Dermatol. 2017;17(1):14.
- West TB, Alster TS. Improvement of infraorbital hyperpigmentation following carbon dioxide laser resurfacing. Dermatol Surgery. 1998;24(6):615–616.
- El-Sinbawy ZG, Abdelnabi NM, Sarhan NE, et al. Clinical & ultrastructural evaluation of the effect of fractional CO2 laser on facial melasma. Ultrastruct Pathol. 2019;43(4–5):135–144.
- Kontochristopoulos G, Kouris A, Platsidaki E, et al. Combination of microneedling and 10% trichloroacetic acid peels in the management of infraorbital dark circles. J Cosmet Laser Ther. 2016;18(5):289–292.
- Zamanian A, Azizi M, Ghasemi M, et al. Comparing the effectiveness of fractional CO2 laser and the combination therapy with micro-needling and topical 10% trichloroacetic acid to remove infra-orbital dark circles in Tehran women. J Cosmet Laser Ther. 2019;21(2):61–64.
- Colferai MMT, Miquelin GM, Steiner D. Evaluation of oral tranexamic acid in the treatment of melasma. J Cosmet Dermatol. 2019;18(5):1495–1501.
- Lee JH, Park JG, Lim SH, et al. Localized intradermal microinjection of tranexamic acid for treatment of melasma in Asian patients: a preliminary clinical trial. Dermatol Surg. 2006;32(5):626–631.
- Tehranchinia Z, Saghi B, Rahimi H. Evaluation of therapeutic efficacy and safety of tranexamic acid local infiltration in combination with topical 4% hydroquinone cream compared to topical 4% hydroquinone cream alone in patients with melasma: a split-face study. Dermatol Res Pract. 2018;2018:1–5.